Page last updated: 2024-10-29

isradipine and Hyperaldosteronism

isradipine has been researched along with Hyperaldosteronism in 1 studies

Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.

Hyperaldosteronism: A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Stölting, G1
Dinh, HA1
Volkert, M1
Hellmig, N1
Schewe, J1
Hennicke, L1
Seidel, E1
Oberacher, H1
Zhang, J1
Lifton, RP1
Urban, I1
Long, M1
Rivalan, M1
Nottoli, T1
Scholl, UI1

Other Studies

1 other study available for isradipine and Hyperaldosteronism

ArticleYear
Isradipine therapy in Cacna1dIle772Met/+ mice ameliorates primary aldosteronism and neurologic abnormalities.
    JCI insight, 2023, Oct-23, Volume: 8, Issue:20

    Topics: Adenoma; Aldosterone; Animals; Autism Spectrum Disorder; Calcium; Female; Humans; Hyperaldosteronism

2023